MS-444 (
, produced by Micromonospora sp. KY7123,is a compoundwhich works as a inhibitor for myosin light chain kinase. In the previous paper2), fermentation, purification, and biological properties of MS-444 were reported. In this paper, we report its structure determination.
Physico-chemical Properties The physico-chemical properties of MS-444 are summarized in Table 1 . MS-444, obtained as yellow needles, didn't show clear melting point, and decomposed around 155°C. The molecular weight (230) and the molecular formula (C13H10O4) of MS-444 were determined by EI-MS and HREI-MS respectively, and carbon-bonded protons, two hydroxy-protons were observed and one of which was hydrogen-bonded (12.6ppm). These data agree well with the above properties.
Two aromatic protons (6.69ppm, 7.13ppm) were assumed to be in ortho position from the 8.8 Hz coupling. In proton-nondecoupling 13C NMR, a 206Hz C-H coupling was observed for 13C that resonates at 138.0 ppm, which indicates the presense of furan ring moiety. The C-H bonding were assigned by the analysis of proton selective decoupling 13C NMRspectra. The whole structure was established by COLOC (Correlation of Long Range Coupling) experiment shown in Fig. 2 . The XHand 13C NMRsignal assignments are summarized in Table 2 . After the construction of the structure, one coupling observed in proton homodecoupling experiment was found to be a strange result; the 0.9Hz coupling observed between 6-H and 9-Hs is unusual for such protons that have 6 bonds between them. Weassume that 9-Hs are somehowstereo-positioned in the optimal way for this long-range^E^E coupling. Discussion MS-444 possesses a unique 4(97/)-naphtho [2,3- c]furanone structure. This structure was found in two synthesis reports3A) as intermediates of aromatic ortho diketones. And while we were preparing this manuscript 5-hydroxy-3-methy-derivative was isolated from Cape aloe5). But there are no previous reports for any biological activities. As MS-444 has a potent bioactivity2), the structure will be able to act as a lead for new drugs.
Experimental
Melting point was determined with a Yanagimoto melting point apparatus. EI-MSspectrum was measured with a HITACHIM-80B mass spectrometer. IR spectrum was taken on a JEOLJIR-RFX3001spectrome-ter. NMRspectra were recorded on a Bruker AM400 spectrometer using TMSas an internal standard.
